Research priorities for progressive pulmonary fibrosis in the UK
Stakeholders' priorities can be summarised into five areas: early diagnosis, drug and non-drug treatments, survival and symptom management. Ideally, these topics should guide funding bodies and health policies.
Authors
- Simon P. Hart (ORCID: https://orcid.org/0000-0003-4606-9559)
- Jenny Lynch-Wilson
- Gísli Jenkins (ORCID: https://orcid.org/0000-0002-7929-2119)
- Nazia Chaudhuri (ORCID: https://orcid.org/0000-0003-3325-6996)
- Michael Gibbons (ORCID: https://orcid.org/0000-0001-7099-1872)
- Anne‐Marie Russell (ORCID: https://orcid.org/0000-0002-0468-3537)
- J. Conway (ORCID: https://orcid.org/0000-0003-2719-5779)
- T. M. McMillan (ORCID: https://orcid.org/0000-0002-5278-9889)
- L. Wright
- Laura Fabbri (ORCID: https://orcid.org/0000-0002-8250-6464)
- Steve Jones
- Steve Milward
- Wendy Adams (ORCID: https://orcid.org/0000-0002-2459-7695)
- Katherine Cowan
- Wendy Dickinson
- Maureen Ward
Institutions
- Japan Patent Office (JP)
- East Sussex County Council (GB)
- University of Ulster (GB)
- University of Hull (GB)
- University of Exeter (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- House of Representatives (NL)
- Tameside Hospital (GB)
- National Institute for Health and Care Research (GB)
- United States House of Representatives (US)
- Royal Brompton Hospital (GB)
- Hywel Dda University Health Board (GB)
- Lung Institute (US)
- Birmingham Dental Hospital (GB)
- Nottingham Biomedical Research Centre (GB)
- Imperial College London (GB)
- Hull York Medical School (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/bmjresp-2024-002368
- Citations
- 8
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 3.35
Funders
- Bristol-Myers Squibb
- AstraZeneca
- GlaxoSmithKline
- Biogen
- Galecto
- Veracyte
- National Institute for Health and Care Research
- Daewoong Pharmaceutical Company